From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
MLD-41 Other names MLD-41; MLD; N 1-Methyl-Lysergic Acid Diethylamide; 1-Methyl-LSD; 1-Methyl-N ,N -Diethyllysergamide; Methyl-LSD Routes of administration Oral [ 1] [ 2] Drug class Serotonergic psychedelic ; Hallucinogen
(8β)-N ,N -Diethyl-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide
CAS Number PubChem CID ChemSpider CompTox Dashboard (EPA ) Formula C 21 H 27 N 3 O Molar mass 337.467 g·mol−1 3D model (JSmol )
O=C(N(CC)CC)[C@@H]3/C=C2/c4cccc1c4c(cn1C)C[C@H]2N(C3)C
InChI=1S/C21H27N3O/c1-5-24(6-2)21(25)15-10-17-16-8-7-9-18-20(16)14(12-22(18)3)11-19(17)23(4)13-15/h7-10,12,15,19H,5-6,11,13H2,1-4H3/t15-,19-/m1/s1
Y Key:VQZYKSWQIQANKB-DNVCBOLYSA-N
Y
(verify)
MLD-41 , also known as 1-methyl-LSD , is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).[ 1] [ 2] It has about 33% of the psychoactive potency of LSD.[ 1] [ 2] It has been studied with regard to cross-tolerance with LSD.[ 3] Extensive metabolism of other 1-methylated lysergamides to their secondary amine derivatives , for instance methysergide (1-methylmethylergometrine) conversion into methylergometrine , has been observed.[ 4] [ 5]
MLD-41 produces the head-twitch response , a behavioral proxy of psychedelic effects, in rodents, and with only slightly lower potency than LSD.[ 6]
Society and culture [ edit ]
MLD-41 is not a controlled substance in Canada as of 2025.[ 7]
^ a b c Jacob P, Shulgin AT (1994). "Structure-activity relationships of the classic hallucinogens and their analogs" (PDF) . NIDA Res Monogr . 146 : 74– 91. PMID 8742795 . Archived from the original (PDF) on August 5, 2023.
^ a b c Hoffer A (1965). "D-Lysergic acid diethylamide (LSD): A review of its present status". Clin Pharmacol Ther . 6 : 183– 255. doi :10.1002/cpt196562183 . PMID 14288188 .
^ Abramson HA, Rolo A, Sklarofsky B, Stache J (January 1960). "Production of cross-tolerance to psychosis-producing doses of lysergic acid diethylamide and psilocybin". The Journal of Psychology . 49 (1): 151– 154. doi :10.1080/00223980.1960.9916396 .
^ Majrashi M, Ramesh S, Deruiter J, Mulabagal V, Pondugula S, Clark R, Dhanasekaran M (2017). "Multipotent and Poly-therapeutic Fungal Alkaloids of Claviceps purpurea". In Agrawal DC, Tsay HS, Shyur LF, Wu YC, Wang SY (eds.). Medicinal Plants and Fungi: Recent Advances in Research and Development . Medicinal and Aromatic Plants of the World. Vol. 4. pp. 229– 252. doi :10.1007/978-981-10-5978-0_8 . ISBN 978-981-10-5977-3 . ISSN 2352-6831 . Metabolites of methysergide also exhibit pharmacological activity. Methylergometrine (one of methysergide's metabolites) is responsible for methysergide's therapeutic effects regarding migraine treatment (Müller-Schweinitzer and Tapparelli 1986). [...] The systemic availability of methysergide after oral administration is only 13%, due to a high degree of first-pass metabolism by N-1 demethylation to methylergometrine. After oral administration, the plasma concentrations of the metabolite are considerably higher than those of the parent drug, and the area under the plasma concentration curve (AUC) for methylergometrine is more than ten times greater than for methysergide.
^ Müller-Schweinitzer E, Tapparelli C (March 1986). "Methylergometrine, an active metabolite of methysergide". Cephalalgia: An International Journal of Headache . 6 (1): 35– 41. doi :10.1046/j.1468-2982.1986.0601035.x . PMID 3698092 . S2CID 5778173 .
^ Corne SJ, Pickering RW (1967). "A possible correlation between drug-induced hallucinations in man and a behavioural response in mice". Psychopharmacologia . 11 (1): 65– 78. doi :10.1007/BF00401509 . PMID 5302272 .
^ "Controlled Drugs and Substances Act" . Department of Justice Canada . Retrieved 19 January 2026 .
No ring subs. 4-Hydroxytryptamines 5-Hydroxytryptamines 5-Methoxytryptamines Other ring subs. α-Alkyltryptamines Others
Ergolines /lysergamides (e.g., LSD )
Ibogalogs (e.g., ibogainalog , tabernanthalog , Pharm-136 )
O -Methylnordehydrobufotenine
Partial ergolines (e.g., NDTDI , RU-28306 , CT-5252 )
Piperidinylethylindoles (e.g., pip-T )
Pyrrolidinylethylindoles (e.g., pyr-T , 5-MeO-pyr-T )
Pyrrolidinylmethylindoles (e.g., MPMI , 4-HO-MPMI (lucigenol) , 5-MeO-MPMI , MSP-2020 )
Tetrahydropyridinylindoles (e.g., RU-28253 (5-MeO-THPI) , NEtPhOH-THPI )
Others: 2C-B-AN
2C-DB
2C-G-x (e.g., 2C-G-3 , 2C-G-5 )
β-Keto-2C-B (βk-2C-B)
β-Keto-2C-I (βk-2C-I)
β-Methyl-2C-B (BMB)
(e.g., BOB , BOD , BOHB )
(e.g., HOT-2 , HOT-7 , HOT-17 )
N -Ethyl-2C-B
(e.g., 2CB-2-EtO , 2CD-2-EtO , 2CD-5-EtO , 2CE-5-EtO , 2CE-5iPrO , 2CT-5-EtO , 2CT2-2-EtO , 2CT7-2-EtO , ASR-2001 (2CB-5-PrO) )
Others
25B-NAcPip
2-DM-DOM
4-HA
5-DM-DOM
Benzofurans (e.g., 5-APB , 5-APDB , 6-APB , 6-APDB , F , F-2 , F-22 )
Benzothiophenes (e.g., 5-APBT , 6-APBT )
BMB-202
CT-5172
DMAs (e.g., 2,4-DMA , 3,4-DMA )
Fenfluramine
MMA (3-MeO-4-MA)
Norfenfluramine
(e.g., 25D-NM-NDEAOP , DOB-NDEPA , DOI-NDEPA , DOM-NDEPA , DOTFM-NDEPA , M-NDEPA , TMA-2-NDEPA )
PMA (4-MA)
Thio-2Cs (e.g., 2C-5-TOET )
Thio-DOx (e.g., 2-TOM , 5-TOET , 5-TOM , TOMSO )
(e.g., TMA-3 , TMA-4 , TMA-5 )
ZDCM-04 (DOC-fenethylline)
1-Aminomethylindanes (e.g., 2CB-Ind , jimscaline )
2-Aminoindanes (e.g., DOM-AI )
3-Benzazepines (e.g., lorcaserin )
3-Phenylpiperidines (e.g., LPH-5 , LPH-48 )
Benzocyclobutenes (e.g., 2CBCB-NBOMe , TCB-2 , tomscaline )
Benzoxepins (e.g., BBOX , IBOX , TFMBOX )
DMBMPP (juncosamine)
Ergolines /lysergamides (e.g., LSD )
Partial ergolines (e.g., NDTDI , DEIMDHPCA , DEMPDHPCA , DEMTMPDHPCA , DEMNDHPCA )
Phenylcyclopropylamines (e.g., DMCPA , TMT )
Phenyloxazolamines (aminorexes ) (e.g., 2C-B-aminorex )
Pyridopyrroloquinoxalines (e.g., IHCH-7113 )
Z3517967757
ZC-B
Others
9-Oxaergolines (e.g., RU-29717 )
γ-Carbolines (e.g., tiflucarbine )
Arylpiperazines (e.g., 2C-B-PP , 2-NP , mCPP , MK-212 , ORG-12962 , pCPP , pFPP , quipazine , TFMPP , VCU-1012 )
Dihydrobenzoxazines (e.g., efavirenz )
Phenoxyethylamines (e.g., CT-4719 , ORG-37684 )
Pyridopyrroloquinoxalines (e.g., IHCH-7113 )
Quinazolinylethylamines (e.g., RH-34 )
Natural sources
Tryptamines: Acacia spp. (e.g., Acacia acuminata , Acacia confusa )
Ayahuasca and vinho de Jurema (e.g., Psychotria viridis (chacruna) , Dipolopterys cabrerana (chaliponga, chacruna) , Mimosa tenuiflora (Mimosa hostilis ; jurema) )
Brosimum (e.g., Brosimum acutifolium (takini) )
Hallucinogenic snuffs (e.g., Anadenanthera peregrina (yopo, jopo, cohoba, parica, ebene) , Anadenanthera colubrina (vilca, cebil) )
Incilius alvarius (Bufo alvarius ; Colorado River toad, Sonoran Desert toad; bufo)
Psilocybin-containing mushrooms (magic mushrooms, shrooms) (e.g., Psilocybe cubensis , Psilocybe mexicana (teonanacatl) )
Lysergamides: Achnatherum robustum (sleepy grass)
Epichloë spp.
Ergot (Claviceps ) (e.g., Claviceps purpurea , Claviceps paspali )
Morning glory (Convolvulaceae) seeds (e.g., Ipomoea tricolor (tlitliltzin, badoh negro; Ipomoea violacea ) , Ipomoea corymbosa (coaxihuitl, ololiúqui; Rivea Corymbosa , Turbina Corymbosa ) , Argyreia nervosa (Hawaiian baby woodrose; HBWR) )
Periglandula spp. (e.g., Periglandula ipomoeae , Periglandula clandestina )
Ergolines (incl. lysergines )Clavines (6,8-dimethylergolines)Lysergamides (lysergic acid amides)
Psychedelic lysergamides: 1B-LSD
1BP-LSD
1Bz-LSD
1cP-AL-LAD
1cP-LSD
1cP-MiPLA
1D-AL-LAD
1D-LSD
1DD-LSD
1F-LSD
1Fe-LSD
1H-LSD
1P-AL-LAD
1P-ETH-LAD
1P-LSD
1P-MiPLA
1S-LSD
1SB-LSD (1BS-LSD)
1T-AL-LAD
1T-LSD
1V-LSD
2,3-Dihydro-LSD
AL-LAD
ALA-10 (1-acetyl-LAE)
ALD-52 (1-acetyl-LSD)
BU-LAD
CPM-LAD
CYP-LAD
Diallyllysergamide (DAL)
Dimethyllysergamide (DAM-57)
Diisopropyllysergamide (DiPLA)
Dipropyllysergamide (DPL)
Ergine (lysergic acid amide; LSA; LA-111; lysergamide)
Ergometrine (ergonovine, ergobasine)
ETH-LAD
Ethylcyclopropyllysergamide (EcPLA)
Ethylisopropyllysergamide (EiPLA)
Ethylpropyllysergamide (EPLA; LEP-57)
Ethyltrifluoroethyllysergamide (ETFELA)
IP-LAD
Isoergine (isolysergic acid amide; iso-LSA; iso-LA; isolysergamide)
Isopropyllysergamide (iPLA; LAiP)
Lysergic acid diethylamide (LSD; d -LSD; lysergide)
Lysergic acid ethylamide (LAE-32, LAE)
Lysergic acid hydroxyethylamide (LSH, LAH)
Lysergic acid methylamide (LAM)
Lysergic acid methylethylamide (LME-54)
Lysergic acid morpholide (LSM-775)
Lysergic acid propylamide (LAP)
Lysergic acid pyrrolidide (LPD-824)
Lysergic acid 2-butylamide (LSB)
Lysergic acid 2,4-dimethylazetidide (LA-SS-Az, LSZ, LA-Azetidine)
Lysergic acid 2-pentylamide (2-LSP)
Lysergic acid 3-pentylamide (LSP, 3-LSP)
Methylergometrine (methylergonovine, methylergobasine; Methergine)
Methylisopropyllysergamide (MiPLA)
Methylpropyllysergamide (LAMPA, LMP-55)
Methysergide (1-methylmethylergonovine; UML-491)
MLA-74 (1-methyl-LAE)
MLD-41 (1-methyl-LSD)
MPD-75 (1-methyllysergic acid pyrrolidide)
NBOMe-LAD
OML-632 (1-hydroxymethyl-LSD)
PARGY-LAD
PRO-LAD
TRALA-12 (didehydro-LSD; DDH-LSD)
Ergopeptines (peptide ergolines)Partial ergolines Related compounds Natural sources